Phibro Animal Health Corporation (PAHC) Insider Sells $357,000.00 in Stock
Phibro Animal Health Corporation (NASDAQ:PAHC) insider Dean J. Warras sold 10,000 shares of Phibro Animal Health Corporation stock in a transaction that occurred on Friday, September 15th. The shares were sold at an average price of $35.70, for a total value of $357,000.00. Following the sale, the insider now owns 10,000 shares in the company, valued at $357,000. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Phibro Animal Health Corporation (NASDAQ:PAHC) opened at 35.40 on Friday. The stock has a market cap of $1.41 billion, a PE ratio of 21.99 and a beta of 1.36. Phibro Animal Health Corporation has a 1-year low of $24.83 and a 1-year high of $40.25. The stock has a 50 day moving average price of $37.87 and a 200 day moving average price of $33.97.
Phibro Animal Health Corporation (NASDAQ:PAHC) last posted its quarterly earnings data on Wednesday, August 30th. The company reported $0.39 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.35 by $0.04. The firm had revenue of $194.84 million during the quarter, compared to analysts’ expectations of $192.47 million. Phibro Animal Health Corporation had a return on equity of 47.88% and a net margin of 8.45%. The business’s quarterly revenue was up 3.0% on a year-over-year basis. During the same quarter last year, the firm earned $0.32 EPS. On average, analysts predict that Phibro Animal Health Corporation will post $1.56 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 27th. Stockholders of record on Wednesday, September 6th will be given a $0.10 dividend. The ex-dividend date is Friday, September 1st. This represents a $0.40 dividend on an annualized basis and a dividend yield of 1.13%. Phibro Animal Health Corporation’s payout ratio is 24.69%.
TRADEMARK VIOLATION WARNING: This news story was published by Daily Political and is owned by of Daily Political. If you are viewing this news story on another website, it was illegally stolen and republished in violation of US & international copyright laws. The legal version of this news story can be accessed at https://www.dailypolitical.com/2017/09/23/phibro-animal-health-corporation-pahc-insider-sells-357000-00-in-stock.html.
Several research firms have commented on PAHC. Piper Jaffray Companies set a $35.00 target price on Phibro Animal Health Corporation and gave the stock a “buy” rating in a report on Friday, July 21st. BidaskClub downgraded Phibro Animal Health Corporation from a “strong-buy” rating to a “buy” rating in a report on Wednesday, June 14th. Bank of America Corporation reissued an “underperform” rating and issued a $33.00 target price on shares of Phibro Animal Health Corporation in a report on Wednesday, August 23rd. Finally, Credit Suisse Group downgraded Phibro Animal Health Corporation from an “outperform” rating to a “neutral” rating and boosted their target price for the stock from $29.00 to $36.00 in a report on Friday, June 2nd. Two equities research analysts have rated the stock with a sell rating, one has assigned a hold rating and five have issued a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $34.00.
Several institutional investors have recently bought and sold shares of PAHC. Janus Henderson Group PLC acquired a new stake in Phibro Animal Health Corporation during the 2nd quarter worth about $6,353,000. AJO LP purchased a new position in shares of Phibro Animal Health Corporation during the 2nd quarter valued at about $5,815,000. FMR LLC raised its stake in shares of Phibro Animal Health Corporation by 31.9% during the 2nd quarter. FMR LLC now owns 584,463 shares of the company’s stock valued at $21,654,000 after buying an additional 141,274 shares during the last quarter. Vanguard Group Inc. raised its stake in shares of Phibro Animal Health Corporation by 8.2% during the 1st quarter. Vanguard Group Inc. now owns 1,729,406 shares of the company’s stock valued at $48,597,000 after buying an additional 130,935 shares during the last quarter. Finally, Ameriprise Financial Inc. raised its stake in shares of Phibro Animal Health Corporation by 50.6% during the 2nd quarter. Ameriprise Financial Inc. now owns 339,996 shares of the company’s stock valued at $12,599,000 after buying an additional 114,230 shares during the last quarter. 48.06% of the stock is owned by hedge funds and other institutional investors.
Phibro Animal Health Corporation Company Profile
Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.
Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.